EUVIMEDEUVIMED entdecken
Crossref

Oral administration of recombinant outer membrane protein A-based nanovaccine affords protection against Aeromonas hydrophila in zebrafish

Mave Harshitha, Ruveena D'souza, Sadanand Dangari Akshay, Ashwath Nayak, Somanath Disha, Vankadari Aditya, Uchangi Satyaprasad Akshath, Saurabh Dubey, Hetron Mweemba Munang'andu, Anirban Chakraborty, Indrani Karunasagar, Biswajit Maiti

World Journal of Microbiology and Biotechnology · 2024

DOI: 10.1007/s11274-024-04059-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Microbiology and Biotechnology, 2024. Verfasst von Mave Harshitha und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nitte (Deemed to be University), Nitte University Centre for Science Education and Research, Department of Bio & Nano Technology, Paneer Campus, Dera…. Hauptthemen laut MEDLINE: Zebrafish, Aeromonas hydrophila, Bacterial Outer Membrane Proteins, Fish Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Department of Science and Technology (DST), Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aeromonas hydrophila, an opportunistic warm water pathogen, has always been a threat to aquaculture, leading to substantial economic losses. Vaccination of the cultured fish would effectively prevent Aeromoniasis, and recent advancements in nanotechnology show promise for efficacious vaccines. Oral delivery would be the most practical and convenient method of vaccine delivery in a grow-out pond. This study studied the immunogenicity and protective efficacy of a nanoparticle-loaded outer membrane protein A from A. hydrophila in the zebrafish model. The protein was over-expressed, purified, and encapsulated using poly lactic-co-glycolic acid (PLGA) nanoparticles via the double emulsion method. The PLGA nanoparticles loaded with recombinant OmpA (rOmpA) exhibited a size of 295 ± 15.1 nm, an encapsulation efficiency of 72.52%, and a polydispersity index of 0.292 ± 0.07. Scanning electron microscopy confirmed the spherical and isolated nature of the PLGA-rOmpA nanoparticles. The protective efficacy in A. hydrophila-infected zebrafish after oral administration of the nanovaccine resulted in relative percentage survival of 77.7. Gene expression studies showed significant upregulation of immune genes in the vaccinated fish. The results demonstrate the usefulness of oral administration of nanovaccine-loaded rOmpA as a potential vaccine since it induced a robust immune response and conferred adequate protection against A. hydrophila in zebrafish, Danio rerio.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ZebrafishAeromonas hydrophilaBacterial Outer Membrane ProteinsFish DiseasesBacterial VaccinesNanoparticlesGram-Negative Bacterial InfectionsRecombinant ProteinsAnimalsAdministration, OralPolylactic Acid-Polyglycolic Acid CopolymerVaccinationNanovaccines

Stichwörter der Autor:innen

Aeromonas hydrophilaNanovaccineOuter membrane protein A

Substanzen

Bacterial Outer Membrane ProteinsBacterial VaccinesRecombinant ProteinsOMPA outer membrane proteinsPolylactic Acid-Polyglycolic Acid CopolymerNanovaccines

Autor:innen und Institutionen

  • Nitte (Deemed to be University), Nitte University Centre for Science Education and Research, Department of Bio & Nano Technology, Paneer Campus, Deralakatte, Mangalore, 575018, India.
  • Nitte (Deemed to be University), Nitte University Centre for Science Education and Research, Department of Infectious Diseases & Microbial Genomics, Paneer Campus, Deralakatte, Mangalore, 575018, India.
  • Faculty of Veterinary Medicine, Department of Production Animal Clinical Sciences, Section of Experimental Biomedicine, Norwegian University of Life Sciences, Ås, Norway.
  • Department of Biosciences and Aquaculture, Nord University, PB 1490, Bodø, 8049, Norway.
  • Nitte (Deemed to be University), Nitte University Centre for Science Education and Research, Department of Molecular Genetics & Cancer, Paneer Campus, Deralakatte, Mangaluru, 575018, India.
  • Nitte (Deemed to be University), DST Technology Enabling Centre, Paneer Campus, Deralakatte, Mangaluru, 575018, India.

Förderung

  • Department of Science and Technology (DST), Government of India

Zitieren

APA

Harshitha, M., D'souza, R., Akshay, S. D., Nayak, A., Disha, S., Aditya, V., Akshath, U. S., Dubey, S., Munang'andu, H. M., Chakraborty, A., Karunasagar, I., & Maiti, B. (2024). Oral administration of recombinant outer membrane protein A-based nanovaccine affords protection against Aeromonas hydrophila in zebrafish. World Journal of Microbiology and Biotechnology. https://doi.org/10.1007/s11274-024-04059-y

Vancouver

Harshitha M, D'souza R, Akshay SD, Nayak A, Disha S, Aditya V, et al. Oral administration of recombinant outer membrane protein A-based nanovaccine affords protection against Aeromonas hydrophila in zebrafish. World Journal of Microbiology and Biotechnology. 2024. doi:10.1007/s11274-024-04059-y

BibTeX
@article{Harshitha2024,
  author = {Harshitha, Mave and D'souza, Ruveena and Akshay, Sadanand Dangari and Nayak, Ashwath and Disha, Somanath and Aditya, Vankadari and Akshath, Uchangi Satyaprasad and Dubey, Saurabh and Munang'andu, Hetron Mweemba and Chakraborty, Anirban and Karunasagar, Indrani and Maiti, Biswajit},
  title = {Oral administration of recombinant outer membrane protein A-based nanovaccine affords protection against Aeromonas hydrophila in zebrafish},
  journal = {World Journal of Microbiology and Biotechnology},
  year = {2024},
  doi = {10.1007/s11274-024-04059-y}
}
Kostenlos starten →